News & Press: Latest News

MDMA Statement on House Subcommittee on Health Vote on “21st Century Cures Act”

Friday, May 15, 2015  
Share |

MDMA Statement on House Subcommittee on Health Vote on “21st Century Cures Act”


WASHINGTON, DC – Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement today following the House Energy and Commerce’s Subcommittee on Health vote on the “21st Century Cures Act:”
 
“MDMA thanks Subcommittee Chairman Joe Pitts and Ranking Member Gene Green for their bipartisan work on the ‘21st Century Cures Act,’ and for recognizing the importance of medical technology innovation in answering the pressing challenges facing America’s health care ecosystem.
 
“This legislation provides substantive proposals to improve the regulatory process, while addressing ongoing challenges in obtaining adequate reimbursement for the cures and treatments that patients need.
 
“Today’s vote marks another important milestone in increasing access for patients and providers to the life-saving medical technologies being developed by America’s innovators.
 
“MDMA will continue to work with the Members of the House of Representatives and Senate to enhance proposals that will advance our shared objectives to improve patient care and innovation.”
 
 
                                                                                                        ###